En Route to Novel Furanoside Mimics through Stereoselective Zinc-Mediated Propargylation of N-Benzyl Glycofuranosylamines Using Ultrasound Activation

Cyril Nicolas; Francis Engo-Ilanga; Chloé Cocaud; Olivier R. Martin

doi:10.1055/s-0034-1379551

Synlett, Table of Contents

Synlett 2015; 26(02): 187-192
DOI: 10.1055/s-0034-1379551

letter

En Route to Novel Furanoside Mimics through Stereoselective Zinc-Mediated Propargylation of N-Benzyl Glycofuranosylamines Using Ultrasound Activation

Cyril Nicolas

Institut de Chimie Organique et Analytique, UMR 7311, Université d’Orléans and CNRS, BP 6759, 45067 Orléans cedex 2, France Fax: +33(238)417281 Email: olivier.martin@univ-orleans.fr

,

Francis Engo-Ilanga

Institut de Chimie Organique et Analytique, UMR 7311, Université d’Orléans and CNRS, BP 6759, 45067 Orléans cedex 2, France Fax: +33(238)417281 Email: olivier.martin@univ-orleans.fr

,

Chloé Cocaud

Institut de Chimie Organique et Analytique, UMR 7311, Université d’Orléans and CNRS, BP 6759, 45067 Orléans cedex 2, France Fax: +33(238)417281 Email: olivier.martin@univ-orleans.fr

,

Olivier R. Martin*

Institut de Chimie Organique et Analytique, UMR 7311, Université d’Orléans and CNRS, BP 6759, 45067 Orléans cedex 2, France Fax: +33(238)417281 Email: olivier.martin@univ-orleans.fr

› Author Affiliations

Abstract

All articles of this category

Abstract

Preliminary results on a novel zinc-mediated, ultrasound-promoted chain extension of glycofuranosylamines with a propargyl group are reported. The procedure was applied to d-arabino and d-xylo substrates to give, via Cram-chelate transition states, 1-C-1-(3-trimethylsilyl-2-propynyl)-1-benzylamino pentionols in moderate to good yields and acceptable stereoselectivities (syn/anti ≥4:1). To apply the reaction to the synthesis of galactofuranoside mimics, the d-xylo intermediate was cyclized to afford a 1-C-1-(2-propynyl)-1,4-dideoxy-1,4-imino-l-arabinitol derivative in excellent yield. This building block was used in three examples of CuAAC click reactions with azide compounds to provide the corresponding galactofuranoside mimics.

Key words

propargylation - N-benzyl glycofuranosylamines - stereoselective synthesis - iminosugars - Huisgen cycloaddition - furanoside mimics

Full Text

References

References and Notes
1 Carbohydrates in Chemistry and Biology . Ernst B, Hart GW, Sinay S. Wiley; New York: 2000
2 Iminosugars: From Synthesis to Therapeutic Applications . Compain P, Martin OR. Wiley-VCH; Weinheim: 2007

3a Kajimoto T, Node M. Curr. Top. Med. Chem. 2009; 9: 13
3b Cullen V, Sardi P, Ng J, Xu YH, Sun Y, Tomlinson JJ, Kolodziej P, Kahn I, Saftig P, Woulfe J, Rochet JC, Glicksman MA, Cheng SH, Grabowski GA, Shihabuddin LS, Schlossmacher MG. Ann. Neurol. 2011; 69: 940
3c Lopez O, Merino-Montiel P, Martos S, Gonzalez-Benjumea A In SPR Carbohydrate Chemistry. Pilar Rauter A, Lindhorst T. RSC Publishing; Cambridge: 2012. 215–262
3d Kim JH, Resende R, Wennekes T, Chen HM, Bance N, Buchini S, Watts AG, Pilling P, Streltsov VA, Petric M, Liggins R, Barrett S, McKimm-Breschkin JL, Niikura M, Withers SG. Science 2013; 340: 71
3e Lahiri R, Ansari AA, Vankar YD. Chem. Soc. Rev. 2013; 42: 5102

4a Descroix K, Pesnot T, Yoshimura Y, Gehrke SS, Wakarchuk W, Palcic MM, Wagner GK. J. Med. Chem. 2012; 55: 2015
4b Merino P, Tejero T, Delso I, Hurtado-Guerrero R, Gomez-Sanjuan A, Sadaba D. Mini-Rev. Med. Chem. 2012; 12: 1455
4c Evitt A, Tedaldi L, Wagner GK. Chem. Commun. 2012; 48: 11856
4d Tedaldi L, Wagner GK. Med. Chem. Commun. 2014; 5: 1106 ; and references cited therein

5 Taha HA, Richards MR, Lowary TL. Chem. Rev. 2013; 113: 1851 ; and references 1–10 cited therein
6 Brennan PJ. Tuberculosis 2003; 83: 91
7 Pan F, Jackson M, Ma YF, McNeil M. J. Bacteriol. 2001; 183: 3991
8 Richards MR, Lowary TL. ChemBioChem 2009; 10: 1920 ; and references therein

9a Rose NL, Completo GC, Lin S, McNeil MR, Palcic MM, Lowary TL. J. Am. Chem. Soc. 2006; 128: 6721
9b Breton C, Snajdrova L, Jeanneau C, Koca J, Imberty A. Glycobiology 2006; 16: 29R
9c Berg S, Kaur D, Jackson M, Brennan PJ. Glycobiology 2007; 17: 35R
9d Alderwick L, Dover L, Veerapen N, Gurcha S, Kremer L, Roper D, Pathak A, Reynolds R, Besra G. Protein Expression Purif. 2008; 58: 332
9e Szczepina MG, Zheng RB, Completo GC, Lowary TL, Pinto BM. ChemBioChem 2009; 10: 2052
9f May JF, Levengood MR, Splain RA, Brown CD, Kiessling LL. Biochemistry 2012; 51: 1148
9g Levengood MR, Splain RA, Kiessling LL. J. Am. Chem. Soc. 2011; 133: 12758
9h Wheatley RW, Zheng RB, Richards MR, Lowary TL, Ng KK. S. J. Biol. Chem. 2012; 287: 28132
9i Poulin MB, Zhou R, Lowary TL. Org. Biomol. Chem. 2012; 10: 4074

10 Lowary TL, Li J. Med. Chem. Commun. 2014; 5: 1130 ; and references cited therein

11a Cren S, Gurcha SS, Blake AJ, Besra GS, Thomas NR. Org. Biomol. Chem. 2004; 2: 2418
11b Schramm VL. ACS Chem. Biol. 2013; 8: 71

12a Liautard V, Christina AE, Desvergnes V, Martin OR. J. Org. Chem. 2006; 71: 7337
12b Liautard V, Desvergnes V, Martin OR. Org. Lett. 2006; 8: 1299
12c Desvergnes S, Desvergnes V, Martin OR, Itoh K, Liu HW, Py S. Bioorg. Med. Chem. 2007; 15: 6443
12d Liautard V, Desvergnes V, Itoh K, Liu HW, Martin OR. J. Org. Chem. 2008; 73: 3103
12e Liautard V, Desvergnes V, Martin OR. Tetrahedron: Asymmetry 2008; 19: 1999
12f Liautard V, Desvergnes V, Martin OR. Carbohydr. Res. 2008; 343: 2111

13 Unpublished results.
14 Ferrières V, Bertho JN, Plusquellec D. Carbohydr. Res. 1998; 311: 25
15 Serra-Vinardell J, Díaz L, Casas J, Grinberg D, Vilageliu L, Michelakakis H, Mavridou I, Aerts JM. F. G, Decroocq C, Compain P, Delgado A. ChemMedChem 2014; 9: 1744
16 Biela A, Oulaïdi F, Gallienne E, Górecki M, Frelek J, Martin OR. Tetrahedron 2013; 69: 3348
17 Behr J.-B, Hottin A, Ndoye A. Org. Lett. 2012; 14: 1536
18 Acharya HP, Miyoshi K, Kobayashi Y. Org. Lett. 2007; 9: 3535
19 Knochel P. Handbook of Functionalized Organometallics. Wiley-VCH; Weinheim: 2005

20a Rao JP, Rao BV, Swarnalatha JL. Tetrahedron Lett. 2010; 51: 3083
20b Rajender A, Rao JP, Rao VB. Tetrahedron: Asymmetry 2011; 22: 1306

21a Organozinc Reagents . Knochel P, Jones P. Oxford University Press; New York: 1999
21b Kanai K, Wakabayashi H, Honda T. Org. Lett. 2000; 2: 2549
21c Honda T, Wakabayashi H, Kanai K. Chem. Pharm. Bull. 2002; 50: 307

22 Synthetic Organic Sonochemistry . Luche JL. Plenum Press; New York: 1998
23 Suslick KS, Doktycz S. J. Am. Chem. Soc. 1989; 111: 2342
24 Procedure A: In a 10-mL round-bottom flask under an argon atmosphere were added zinc dust (96.2 mg, 1.47 mmol) and iodine (11.2 mg, 0.04 mmol). The flask was placed under vacuum and the vessel was heated with a heat gun during 5 min. The vessel was filled with argon and allowed to reach r.t. The cycle was repeated once and anhyd THF (2 mL) was then added followed by 3-bromo-1-trimethylsilyl-1-propyne at 0 °C (53 μL, 0.32 mmol; mixture A). The reaction mixture was allowed to warm to r.t. and stirred for a further 2 h. In parallel, a solution of the N-benzyl-2,3,5-tri-O-benzyl-α/β-furanosylamine (0.10 mmol) in anhyd THF (2 mL) under argon was prepared in a 10-mL round-bottom flask (mixture B). Solution A was added to solution B via cannula, avoiding transferring too much zinc powder into solution B. The reaction mixture was stirred under ultrasonication for 48 h (45 °C, 42 kHz, 0.47 W/cm²). The resulting mixture was then filtered through Celite^® and the residue was washed with EtOAc. The organic phase was washed with H₂O, aq NH₄Cl, sat. aq NaHCO₃ and dried over MgSO₄. The organic phase was filtered and concentrated under vacuum. The residue was purified by column chromatography (silica gel, petroleum ether–EtOAc, 8:2) to give the corresponding propargylated pentitols as a mixture of two diastereomers.
25 Procedure B: In a 10-mL round-bottom flask under an argon atmosphere were added zinc dust (96.2 mg, 1.47 mmol) and iodine (11.2 mg, 0.04 mmol). The flask was placed under vacuum and the vessel was heated with a heat gun during 5 min. The vessel was filled with argon and allowed to reach r.t. The cycle was repeated once and anhyd THF (4 mL) was then added followed by 3-bromo-1-trimethylsilyl-1-propyne (53 μL, 0.32 mmol) and the N-benzyl-2,3,5-tri-O-benzyl-α/β-furanosylamine (0.10 mmol) under argon atmosphere. The reaction mixture was stirred under ultrasonication for 48 h (45 °C, 42 kHz, 0.47 W/cm²). The resulting mixture was then filtered through Celite^® and washed with EtOAc. The organic phase was washed with H₂O, aq NH₄Cl, sat. aq NaHCO₃ and dried over MgSO₄. The organic phase was filtered and concentrated under vacuum. The residue was purified by column chromatography (silica gel, petroleum ether–EtOAc, 8:2) to give the corresponding propargylated pentitols as a mixture of two diastereomers.

26a Cram DJ, Elhafez FA. A. J. Am Chem. Soc. 1952; 74: 5828
26b Cram DJ, Kopecky KR. J. Am Chem. Soc. 1959; 81: 2748
26c Leitereg TJ, Cram DJ. J. Am Chem. Soc. 1968; 90: 4019

27 Diastereomers of compound 6 could not be separated on regular silica gel column chromatography and were thus further processed as a mixture of isomers.
28 Spectroscopic Data for Selected Compounds:(1R)- and (1S)-1-C-(3-Trimethylsilyl-2-propynyl)-2,3,5-tri-O-benzyl-1-benzylamino-1-deoxy-d-xylitol [(1R)-6 and (1S)-6]: colorless oil; (1R)-6 and (1S)-6 were obtained as a 8:2 mixture of diastereomers; [α]_D ²⁰ −17.3° (CHCl₃, c = 0.5). ¹H NMR (400 MHz, CDCl₃/TMS): δ = 7.19–7.36 (m, 20 H), 4.34–4.71 (m, 6 H), 4.12 (d, J = 6.5 Hz, 0.8 H), 4.08–4.11 (dd, J = 8.2, 5.8 Hz, 0.8 H), 4.00–4.06 (m, 0.2 H), 3.88 (d, J = 12.5 Hz, 0.2 H), 3.85 (d, J = 12.1 Hz, 0.8 H), 3.80–3.82 (m, 0.2 H), 3.78 (br d, J = 6.6 Hz, 0.8 H), 3.62–3.70 (m, 1 H), 3.48–3.62 (m, 2.2 H), 3.33 (dd, J = 9.4, 3.6 Hz, 0.8 H), 3.08 (dd, J = 12.0, 4.0 Hz, 0.2 H), 2.71–2.84 (m, 1 H), 2.63–2.70 (m, 0.2 H), 2.48 (dd, J = 16.7, 9.5 Hz, 0.8 H), 0.06–0.19 (m, 9 H). ¹³C NMR (101 MHz, CDCl₃/TMS): δ = 139.1, 138.7, 138.6, 138.5, 138.4, 138.2, 138.1, 137.9, 127.5–128.8, 104.2, 103.7, 88.0, 87.5, 79.0, 78.9, 77.9, 75.3, 73.9, 73.7, 73.6, 73.2, 73.7, 73.2, 73.0, 71.1, 70.8, 68.0, 66.4, 57.3, 53.9, 50.6, 50.6, 22.5, 20.9, 0.1–0.5. IR (film): 3030, 2862, 2171, 1496, 1453, 1360, 1249, 1207, 1071, 1027, 907, 841, 726, 696, 645 cm^–1. HRMS (ESI): m/z [M + H]⁺ calcd for C₃₉H₄₈NO₄Si: 622.334712; found: 622.334699.(1R)- and (1S)-1-C-(3-Trimethylsilyl-2-propynyl)-N-benzyl-2,3,5-tri-O-benzyl-1,4-dideoxy-1,4-imino-l-arabinitol (7): light yellow oil; 8:2 mixture of diastereomers (1R)-7 and (1S)-7; [α]_D ²⁰ −14.5° (CHCl₃, c = 0.4). ¹H NMR (400 MHz, CDCl₃/TMS): δ = 7.14–7.39 (m, 20 H), 4.22–4.60 (m, 6 H), 4.06–4.12 (m, 0.4 H), 3.97 (d, J = 10.9 Hz, 0.8 H), 3.95 (br s, 0.8 H), 3.91–3.94 (m, 0.2 H), 3.88 (br s, 0.8 H), 3.76 (d, J = 13.9 Hz, 0.8 H), 3.71 (d, J = 14.6 Hz, 0.2 H), 3.53–3.58 (m, 0.4 H), 3.27–3.38 (m, 1.8 H), 3.20–3.26 (m, 0.2 H), 3.07–3.16 (m, 1.6 H), 2.56 (dd, J = 16.6, 9.3 Hz, 0.8 H), 2.44–2.59 (m, 0.2 H), 2.34 (br s, 0.2 H), 2.40 (dd, J = 16.6, 5.1 Hz, 0.8 H), 0.05–0.19 (m, 9 H). ¹³C NMR (101 MHz, CDCl₃/TMS): δ = 139.6, 139.5, 138.7, 138.5, 125.4–129.2, 106.0, 105.2, 86.8, 86.3, 86.0, 85.4, 83.5, 82.7, 73.3, 73.0, 72.7, 71.7, 71.6, 71.0, 72.0, 70.6, 69.7, 66.5, 65.2, 63.8, 59.0, 51.4, 20.8, 19.5, 0.3. IR (film): 3029, 2858, 2172, 1495, 1453, 1363, 1248, 1205, 1097, 1071, 1027, 908, 839, 731, 695, 645 cm^–1. HRMS (ESI): m/z [M + H]⁺ calcd for C₃₉H₄₆NO₃Si: 604.324147; found: 604.324106.(1R)-1-C-[1-(3-Hydroxypropyl)triazol-4-ylmethyl]-2,3,5-tri-O-benzyl-1,4-dideoxy-1,4-imino-l-arabinitol [(1R)-10a]: amber oil; [α]_D ²⁰ –4.24° (CHCl₃, c = 1.1). ¹H NMR (400 MHz, CDCl₃/TMS): δ = 7.15–7.35 (m, 21 H), 6.83 (s, 1 H), 4.55 (d, J = 12.2 Hz, 1 H), 4.46 (d, J = 12.3 Hz, 1 H), 4.45 (d, J = 12.0 Hz, 1 H), 4.38 (d, J = 12.0 Hz, 1 H), 4.30 (dt, J = 6.7, 2.2 Hz, 2 H), 4.25 (d, J = 12.1 Hz, 1 H), 4.21 (d, J = 11.9 Hz, 1 H), 4.01 (d, J = 12.0 Hz, 1 H), 3.93 (br s, 1 H), 3.71–3.78 (m, 2 H), 3.52 (t, J = 5.8 Hz, 2 H), 3.43 (dt, J = 9.2, 4.5 Hz, 1 H), 3.35 (dd, J = 12.0, 8.0 Hz, 1 H), 3.03–3.17 (m, 3 H), 2.92 (dd, J = 14.4, 4.4 Hz, 1 H), 1.97 (p, J = 6.5 Hz, 2 H). ¹³C NMR (101 MHz, CDCl₃/TMS): δ = 145.7, 139.4, 138.7, 138.5, 138.3, 127.7–129.4, 122.1, 82.4, 82.1, 73.0, 71.4, 70.8, 71.9, 69.1, 66.6, 59.0, 58.8, 46.7, 32.6, 25.1. IR (neat): 3342, 2919, 2861, 1453, 1097, 1068 cm^–1. HRMS (ESI): m/z [M + H]⁺ calcd for C₃₉H₄₅N₄O₄: 633.343529; found: 633.343532.(1R)-1-C-[1-(3-Hydroxypropyl)triazol-4-ylmethyl]-1,4-dideoxy-1,4-imino-l-arabinitol [(1R)-11a]: yellow oil; [α]_D ²⁰ –4.24° (CHCl₃, c = 1.1). ¹H NMR (400 MHz, CD₃OD/TMS): δ = 7.79 (s, 1 H), 4.47 (t, J = 7.0 Hz, 2 H), 3.86 (dd, J = 3.7, 1.6 Hz, 1 H), 3.78 (dd, J = 4.0, 1.6 Hz, 1 H), 3.68 (dd, J = 10.8, 4.4 Hz, 1 H), 3.65 (dd, J = 11.2, 4.8 Hz, 1 H), 3.57 (t, J = 6.4 Hz, 2 H), 3.44 (dt, J = 7.3, 4.0 Hz, 1 H), 3.02 (dd, J = 14.7, 7.1 Hz, 1 H), 2.96 (br q, J = 4.8 Hz, 1 H), 2.88 (dd, J = 14.6, 7.5 Hz, 1 H), 2.09 (p, J = 6.5 Hz, 2 H). ¹³C NMR (101 MHz, CD₃OD/TMS): δ = 146.6, 124.2, 81.2, 79.1, 68.4, 63.5, 62.5, 59.3, 48.2, 34.0, 26.1. IR (neat): 3265, 2922, 1652, 1557, 1429, 1216, 1060 cm^–1. HRMS (ESI): m/z [M + H]⁺ calcd for C₁₁H₂₀N₄O₄: 273.155732; found: 273.155429

Supplementary Material

Supporting Information

Primary Data

Primary Data